827 related articles for article (PubMed ID: 19059448)
21. Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia.
Bloch B; Reshef A; Cohen T; Tafla A; Gathas S; Israel S; Gritsenko I; Kremer I; Ebstein RP
Psychiatry Res; 2010 Jan; 175(1-2):38-42. PubMed ID: 19995670
[TBL] [Abstract][Full Text] [Related]
22. Evidence of association of serotonin transporter gene polymorphisms with schizophrenia in a South Indian population.
Vijayan NN; Iwayama Y; Koshy LV; Natarajan C; Nair C; Allencherry PM; Yoshikawa T; Banerjee M
J Hum Genet; 2009 Sep; 54(9):538-42. PubMed ID: 19713975
[TBL] [Abstract][Full Text] [Related]
23. Effect of serotonin-related gene polymorphisms on pathogenesis and treatment response in Korean schizophrenic patients.
Kim YK; Yoon HK
Behav Genet; 2011 Sep; 41(5):709-15. PubMed ID: 21399903
[TBL] [Abstract][Full Text] [Related]
24. Association study of serotonin 2A receptor (5-HT2A) and serotonin transporter (5-HTT) gene polymorphisms with schizophrenia.
Sáiz PA; García-Portilla MP; Arango C; Morales B; Alvarez V; Coto E; Fernández JM; Bascarán MT; Bousoño M; Bobes J
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):741-5. PubMed ID: 17291660
[TBL] [Abstract][Full Text] [Related]
25. Dopamine D2 receptor gene polymorphisms predict well the response to dopamine antagonists at therapeutic dosages in patients with schizophrenia.
Sakumoto N; Kondo T; Mihara K; Suzuki A; Yasui-Furukori N
Psychiatry Clin Neurosci; 2007 Apr; 61(2):174-80. PubMed ID: 17362435
[TBL] [Abstract][Full Text] [Related]
26. [Association of antipsychotic agent-induced weight gain with a polymorphism of the promotor region of the 5-HT2C receptor gene].
Zhang Z; Zhang X; Yao Z; Chen J; Sun J; Yao H; Hou G; Zhang X; Reynolds GP
Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1097-101. PubMed ID: 12425817
[TBL] [Abstract][Full Text] [Related]
27. Amisulpride for the treatment of very-late-onset schizophrenia-like psychosis.
Psarros C; Theleritis CG; Paparrigopoulos TJ; Politis AM; Papadimitriou GN
Int J Geriatr Psychiatry; 2009 May; 24(5):518-22. PubMed ID: 19072747
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia.
Fan JB; Sklar P
Mol Psychiatry; 2005 Oct; 10(10):928-38, 891. PubMed ID: 15940296
[TBL] [Abstract][Full Text] [Related]
29. [Lack of association between the insertion/deletion polymorphism in serotonin transporter gene, T102C polymorphism of the 5HT2A receptor gene and schizophrenia--family based study].
Kapelski P; Hauser J; Skibińska M; Szczepankiewicz A; Dmitrzak-Weglarz M; Budziński B; Gorzkowska K; Czerski PM
Psychiatr Pol; 2010; 44(2):197-206. PubMed ID: 20677439
[TBL] [Abstract][Full Text] [Related]
30. Association between 5-hydroxytryptamine transporter gene-linked polymorphic region and smoking behavior in Chinese males.
Chu SL; Xiao D; Wang C; Jing H
Chin Med J (Engl); 2009 Jun; 122(12):1365-8. PubMed ID: 19567154
[TBL] [Abstract][Full Text] [Related]
31. Catechol-O-methyltransferase Val158Met polymorphism affects therapeutic response to mood stabilizer in symptomatic manic patients.
Lee HY; Kim YK
Psychiatry Res; 2010 Jan; 175(1-2):63-6. PubMed ID: 20004480
[TBL] [Abstract][Full Text] [Related]
32. Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression.
Taylor WD; Steffens DC; Payne ME; MacFall JR; Marchuk DA; Svenson IK; Krishnan KR
Arch Gen Psychiatry; 2005 May; 62(5):537-44. PubMed ID: 15867107
[TBL] [Abstract][Full Text] [Related]
33. Negative symptoms of schizophrenia could explain discrepant data on the association between the 5-HT2A receptor gene and response to antipsychotics.
Hamdani N; Bonnière M; Adès J; Hamon M; Boni C; Gorwood P
Neurosci Lett; 2005 Mar; 377(1):69-74. PubMed ID: 15722190
[TBL] [Abstract][Full Text] [Related]
34. Serotonin transporter gene (5-Htt): association analysis with temporal lobe epilepsy.
Manna I; Labate A; Gambardella A; Forabosco P; La Russa A; Le Piane E; Aguglia U; Quattrone A
Neurosci Lett; 2007 Jun; 421(1):52-6. PubMed ID: 17548158
[TBL] [Abstract][Full Text] [Related]
35. The --1019 C/G polymorphism of the 5-HT(1)A receptor gene is associated with negative symptom response to risperidone treatment in schizophrenia patients.
Wang L; Fang C; Zhang A; Du J; Yu L; Ma J; Feng G; Xing Q; He L
J Psychopharmacol; 2008 Nov; 22(8):904-9. PubMed ID: 18308786
[TBL] [Abstract][Full Text] [Related]
36. Serotonin transporter gene promoter polymorphism and somatoform symptoms.
Hennings A; Zill P; Rief W
J Clin Psychiatry; 2009 Nov; 70(11):1536-9. PubMed ID: 19538902
[TBL] [Abstract][Full Text] [Related]
37. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
Molero P; Ortuño F; Zalacain M; Patiño-García A
Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
[TBL] [Abstract][Full Text] [Related]
38. Analysis of a functional serotonin transporter promoter polymorphism in psoriasis vulgaris.
Mössner R; Stiens G; König IR; Schmidt D; Platzer A; Krüger U; Reich K
Arch Dermatol Res; 2009 Jul; 301(6):443-7. PubMed ID: 18979110
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response.
Reynolds GP; Yao Z; Zhang X; Sun J; Zhang Z
Eur Neuropsychopharmacol; 2005 Mar; 15(2):143-51. PubMed ID: 15695058
[TBL] [Abstract][Full Text] [Related]
40. Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders.
Kim JM; Stewart R; Kim SW; Yang SJ; Shin IS; Kim YH; Yoon JS
Biol Psychiatry; 2007 Sep; 62(5):423-8. PubMed ID: 17482146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
